ARMEN GARO H 4

What Happened
Garo H. Armen, Chairman, Chief Executive Officer and Principal Financial Officer of Agenus, received 5,364 shares of common stock on June 26, 2026. The shares were issued as salary paid in stock (an award/acquisition) at a closing price of $3.03 per share, equal to approximately $16,253. The shares were issued under the company's Amended and Restated 2019 Equity Incentive plan and were fully vested on the date of issuance.

Key Details

• Transaction date: June 26, 2026; filing date: June 30, 2026.
• Price: $3.03 per share (closing price on June 26, 2026).
• Shares acquired: 5,364; total value reported: ~$16,253.
• Shares were issued as salary in lieu of cash and are fully vested on issuance (Footnote F1).
• Shares are held in Dr. Armen’s IRA accounts (F3).
• Other disclosed holdings: 23,950 shares held by the Garo Armen 2020 2 Year AG GRAT (Dr. Armen is trustee) and 5,000 shares owned by Pixie Partners (Dr. Armen is a general partner; he disclaims beneficial ownership to the extent of his pecuniary interest) (F4).
• Filing timing: Form 4 filed June 30, 2026 — this appears to be after the typical two-business-day Form 4 filing deadline for the June 26 transaction.

Context
This transaction reflects compensation paid in stock rather than an open-market purchase or sale. Such awards are common for executive compensation and are administrative in nature; they do not necessarily indicate a change in the insider’s view of the company. The shares were fully vested at issuance and retained in retirement accounts, per the filing.